Carl Zeiss Meditec (ETR:AFX) Trading Up 0% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s share price was up 0% during mid-day trading on Wednesday . The company traded as high as €41.74 and last traded at €41.20. Approximately 72,923 shares traded hands during trading, a decline of 23% from the average daily volume of 94,405 shares. The stock had previously closed at €41.18.

Carl Zeiss Meditec Stock Up 0.0%

The company has a debt-to-equity ratio of 7.41, a current ratio of 2.13 and a quick ratio of 2.47. The firm’s 50 day moving average is €41.95 and its two-hundred day moving average is €44.78. The firm has a market capitalization of $3.84 billion, a P/E ratio of 22.02, a PEG ratio of 2.83 and a beta of 0.98.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.